
|Articles|January 6, 2017
Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/decrease-in-fda-drug-approvals-highlight-specialty" target="_blank">View the story "Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
ADCs in Breast Cancer: Shaping the Future of HER2– and TROP2-Targeted Therapy
2
Study: Many Patients Switching Biologics Because of Perceived Lack of Efficacy Treating Asthma
3
FDA Approves Targeted Combination Therapy for BRCA2-Mutated Prostate Cancer
4
Targeted ADCs Break Through Barriers in HER2-Positive Breast Cancer
5

















































































































































































































